U.S. Orthopedic Biomaterials Market Size & Outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to orthopedic biomaterials market will help companies and investors design strategic landscapes.

Ceramics & bioactive glass biomaterials was the largest segment with a revenue share of 32.67% in 2023. Horizon Databook has segmented the U.S. orthopedic biomaterials market based on ceramics & bioactive glass biomaterials, polymers biomaterials, calcium phosphate cements, metal biomaterials, composites covering the revenue growth of each sub-segment from 2018 to 2030.

According to the estimates provided by American Academy of Orthopedic Surgeons in 2019, about 700,000 total knee replacement surgeries and 400,000 total hip replacement surgeries were performed in the U.S. As the number of replacement surgeries are increasing, the demand for orthopedic implants is also increasing. This is further anticipated to drive the market for orthopedic biomaterials. Furthermore, growing prevalence of osteoporosis and osteoarthritis and increasing geriatric population are expected to drive the market over the forecast period.

According to the estimates provided by the National Osteoporosis Foundation (NOF) in 2014, the U.S. has around 54 million people aged 50 and above affected by osteoporosis, arthritis, and various other low bone mass conditions. Owing to the presence of favorable reimbursement policies and low out-of-pocket expenditures, these patients either opt for reconstruction surgeries or non-operative solutions, such as viscosupplementation, for restoring leg movements and reducing pain. This further creates a strong demand for orthopedic biomaterials in the country.

Moreover, the market penetration and consumer base for orthopedic biomaterials is comparatively high in the country. Owing to this factor, many key players such as Globus Medical, Inc.; Stryker Corporation; DePuy Synthes, Inc.; Zimmer Biomet; Exactech, Inc.; DSM Biomedical; Matexcel; and others have established their manufacturing centers and R&D units in the country. Their presence and strategic initiatives have also created intense competition in the country. This is further anticipated to drive the market in the country.